Congress 2013



Plenary I
Biological Therapy in SLE: a critical analysis of trials for clinical practice. New treatments for SLE: How were they tested, and how are they used in clinical practice?
Van Vollenhoven, Ronald 

Future trials in Lupus: can treatment development be any less risky? 
Merril, Joan

Lessons learned: are all failed trial due to failed treatments?
Furie, Richard

Plenary II
Evidence based induction and maintenance theraphy recommendations for lupus nephritis

Comparison of ACR and EULAR/ERA recommendations
Hahn, Bevra

Standard of Care
Houssiau, Frederic

Use of biologics
Lightstone, Liz

Plenary III
The last decade: advances in pathogenesis, diagnosis and management of neuropsychiatric lupus.

Demystifying neuropsychiatric lupus. Is it possible?
Hanly, John

Glutamate receptor biology and its clinical significance in neuropsychiatricsystemic lupus erythematosus.


Basic Symposium
"Net" relevance to Lupus pathogenesis
Kaplan, Mariana

Neuropathogenic potential of anti-ribosomal P antibodies
gonzalez, alfonso

Epidemiologic Symposium
Lessons from lupus epidemiology around the world (Latin America / GLADEL)
Catoggio, Luis

Lessons from lupus epidemiology around the world (Europe)
Cervera, Ricard

Lessons from lupus epidemiology around the world (USA/Lumina)
AlarcÓn, Graciela

Pediatric Symposium
Gonadal function and preservation of reproductive fitness in juvenile systemic lupus erythematosus
Almeida da Silva, Clovis

Therapy insight: cardiovascular disease in pediatric systemic lupus
Schanberg, Laura

Therapy of lupus nephritis in juvenile patients
Sandborg, Christy

Plenary Industry Symposium | Glaxo Smithkline
The changing face of SLE management
Masardo, Loreto

The changing face of SLE management
Catoggio, Luis

The changing face of SLE management
Van Vollenhoven, Ronald

The changing face of SLE management
Furie, Richard

The changing face of SLE management
Collins, Christopher

The changing face of SLE management
Questions & Answers

Plenary Industry Symposium | Lilly
Clinical challenges and evidence-based solutions in the management of lupus
Cardiel, Mario

Clinical challenges and evidence-based solutions in the management of lupus
Urowitz, Murray

Clinical challenges and evidence-based solutions in the management of lupus
Petri, Michelle

Clinical challenges and evidence-based solutions in the management of lupus
Isenberg, David

Plenary Industry Symposium | Pfizer

What do we need to know about immunogenicity?
Wolbink, Gertjan

Plenary Industry Symposium | UCB
Hitting the mark in SLE care: emerging targets in response to new advances
Van Vollenhoven, Ronald

Hitting the mark in SLE care: emerging targets in response to new advances
Furie, Richard

Hitting the mark in SLE care: emerging targets in response to new advances
Petri, Michelle

Hitting the mark in SLE care: emerging targets in response to new advances
Dorner, Thomas

Hitting the mark in SLE care: emerging targets in response to new advances
Questions & Answers

Ancestral variation in SLE genetics at IRF5 and in the African-American GWAS
Harley, John

Latest GWAS in Mestizos
AlarcÓn Riquelme, Marta

The genetics of SLE, an update and what it means for de patient and de physician
Kimberly, Robert

Invited Lecture

A critical point of view of their relevance for clinical practice
Pisetsky, David

Antimalarials revisited
Ruiz-Irastorza, Guillermo

Evidences for treatment of cutaneous lupus: a dermatologist approach
Werth, Victoria

Getting beyond description: Explaining the causes of disparities by race/ethnicity in SLE
Yelin, Edward

New SLE criteria: are they better?
Petri, Michelle

Novel insights into diagnosis and treatment of antiphospholipid syndrome
Meroni, Pier Luigi

Predictors of major infections on SLE
Shoenfeld, Yehuda

Understanding the challenge of osteoporosis and low vitamin D in lupus
Pereira, Rosa

Up to Date

Cardiovascular risk assessment and treatment: recommendations for daily practice
Manzi, Susan

Challenges in the management of obstetric lupus patients
Levy, Roger

Current thinking about prevition, management and outcomes of the neonatal lupus syndromes
Buyon , Jill

Lupus biopsy: the nephrologist’s point of view
Lightstone, Liz

Malignancies and systemic lupus lessons from a comprehensive review
Clarke, Ann

Major contributions of SLICC group to clinical practice 20-years experience
Urowitz, Murray

Oral Presentations

The year in review
Pisetsky, David 

The year in review 
Hahn, Bevra 

Oral Presentations

Accuracy of systemic lupus international collaborating clinics classification criteria applied to juvenile systemic lupus erythematosus patients
Katsicas, María Martha

Adipokines association with clinical, laboratory and medication correlation with TNF system in SLE patients. Peliminary analysis.
Costa Duarte Lanna, Cristina

Admixture Mapping in Lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation and autoantibody production
Nath, Swapan

Blisibimod, an emerging subcutaneous biologic theraphy for patients with active, moderate-to-severe systemic lupus erythematosus
Scheinberg, Morton

Efficacy and safety of Rontalizumab (anti-interferon-alpha) in SLE patients with restricted immunosuppressant use: results of a randomized, double-blind, placebo-controlled phase 2 study
Kennedy, William

Final results from an opean-label extension study of Epratuzumab (SL0006): maintained improvements in disease activity and clinically meaningful improvements in quality of life in patients with moderate-to-severe systemic lupus erythematosus
Hobbs, Kathryn

Frequency of hematological alterations in patients with systemic lupus erythematosus and its association with vascular thrombosis – GLADEL registration
Martinez Betancur, Octavio

French registry of 189 cases of immune congenital heart block: maternal data analysis
Levesque, Kateri

Hippocampal atrophy in childhood-onset systemic lupus erythematosus
Barbosa, Rosa

Impaired diffusion tensor imaging findings in the corpus callosum and cingulum may underline impaired learning and memory abilities in systemic lupus erythematosus
Paran, Daphna

Interferon-alpha May Impair Endothelial Repair Mechanisms in Patients with SLE Long-Term Outcomes of Children Born to Women with Systemic Lupus Erythematosus
Reynolds, John

Long-term outcomes of children born to women with systemic lupus erythematosus
Vinet, Evelyne

Lupus anticoagulant at first pregnancy visit is predictive of pregnancy loss
Petri, Michelle

Morbidity and mortality in the antiphospholipid sindrome during a 10-year period: A multicentre prospective study of 1000 patients
Serrano, Rosa

Mortality rates among U.S. Medicaid recipients with SLE, 2000-2006
Gomez-Puerta, JosÉ

Neutrophil gelatinase associated lipocalin (NGAL/lipocalin-2) regulates the onset of serum autoantibodies in pristane induced lupus
Putterman, Chaim

Novel urine biomarkers for monitoring disease activity in juvenile lupus nephritis: a prospective longitudinal validation study
Watson, Louise

Outcomes associated with Belimumab in patients with Systemic Lupus Erithematosus (SLE) in clinical practice settings: results from OBServe study in the United States (U.S.)
Collins, Christopher

Predictive atherosclerotic risk factors at inception in a multicentre multinational cohort
Urowitz, Murray

Prevalence and clinical significance of severe infection in patients with systemic lupus erythematosus: preliminary dada from RESELLER (registry of Lupus of the Spanish Society of Rheumatology)
Pego-Reigosa, JosÉ MarÍa

Provisions of quality driven care in childhood-onset Systemic Lupus Erythematosus
Brunner, Hermine

Response to a protein challenge in patients with lupus nephritis and variable degree of glomerular or interstitial damage after maintenance therapy
Bernasconi, Amelia

Risk factors for non-fatal cardiovascular disease in systemic lupus erythematosus: multivariate analysis in a cohort of 306 patients
Inanc, Murat

Risk of myocardial infarction in patients with systemic Lupus Erithematosus: a population-based study
Avina Zubieta, Juan

Risk of nephritis among Danish patients with systemic lupus erythematosus is associated with genetically determined mannose-binding lectin deficiency
Jacobsen, Søren

Safety, pharmacokinetics and pharmacodynamics of AMG 557 (anti-B7RP-1) in subjects with systemic lupus erythematosus: results of a phase 1 multicenter, randomized, double-blind, placebo-controlled, sequential rising single-dose study
Sullivan, Barbara

Safety, pharmacokinetics and pharmacodynamics of AMG 811 (anti-IFN-gamma): Results of a phase I single dose study in subjects with systemic lupus erythematosus
Martin, DA

Serum levels of B-Lymphocyte simulator and A proliferation inducing ligand in patients with lupus nephritis: APRIL as a candidate biomarker
Parodis, Ioannis

SLE18a, a murine 129-derived disease modifier locus on chromosome 3, regulates the expression of Ly108 isoforms in T cells
Carlucci, Francesco

SLE cardiovascular risk equation
Petri, Michelle

Study of anti-müllerian hormone and the relationship with subsequent probability of pregnancy in 112 systemic lupus erythematosus patients exposed or not to cyclophosphamide
Morel, Nathalie

The granulocite signature and organ inflammation in TLR7 responsive mice is RNA and type 1 interferon dependent
Elkon, Keith

The lupus associated TT > a variant on 6Q23 is located in an enhancer element that physically interacts with the TNFAIP3 promoter to influence TNFAIP3 expression
Gaffney, Patrick

The PREDICTS panel of biomarkers is associated with 28-fold increased risk for the presence and progression of atherosclerosis in women with SLE
McMahon, Maureen

Validations of the Lupus Impact Tracker (LIT), a patient-reported outcome (PRO) tool, in a prospective multicenter longitudinal study of Systemic Lupus Erithematosus (SLE) patients
Jolly, Meenakshi

Which lupus trail endpoint best reflect clinical judgement or biomarker improvement?
Thanou, Aikaterini

File: inc_herra_s_related_gallery.htm
Location Map: Discover our Centers in Latin America
Suscribe to our Newsletter
Subscribe and receive all the news in your email.
Contact us
Questions or suggestions please contact Gladel.

File: frontend_view_content.htm